Ambros Therapeutics is a clinical-stage biotechnology company advancing late-stage therapies for severe, underserved diseases beginning with neridronate for Complex Regional Pain Syndrome Type 1 (CRPS-1).
Arkin Entry Stage
Series A
Status
Active
Location
Irvine, CA
Let’s get in touch!